Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Doubek
Observed name:
M Doubek
Institutions:
Central European Institute of Technology,
Masaryk University,
Central European Institute of Technology – Masaryk University,
University Hospital Brno
Observed institutions:
Central European Institute of Technology,
Masaryk University,
Central European Institute of Technology – Masaryk University,
University Hospital Brno
OpenAlex ID:
A5064565748
Recommendations of the European Working Group for Adult ALL
2011
·
Nicola Gökbuget
, R Bassan
, et al.
·
Uni-Med Verlag AG eBooks
·
24
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival
2017
·
M C Fontana
, G Marconi
, et al.
·
Leukemia
·
10
PDF
Monoclonal gammopathy of clinical significance with osteosclerotic lesions – a case report and a literature review
2024
·
Zdeněk Adam
, Zdeněk Řehák
, et al.
·
Klinicka onkologie
·
3
PDF
Chromosome Banding Analysis of Peripheral Blood Lymphocytes Stimulated with IL-2 and CpG Oligonucleotide DSP30 in Patients with Chronic Lymphocytic Leukemia
2013
·
Kristina Štěpanovská
, Gabriela Vaňková
, et al.
·
Klinicka onkologie
·
3
PDF
[Hereditary thrombocytopenia. Differential diagnosis of a case].
2003
·
M Doubek
, P Smejkal
, et al.
·
PubMed
·
2
Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm
2026
·
Olivier Hermine
, Orianne Debeaupuis
, et al.
·
Blood
PDF
Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
2026
·
Andrea Visentin
, Enrico Gaffo
, et al.
·
Leukemia
PDF
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis
2026
·
Stefan Haug
, Wolfgang R. Sperr
, et al.
·
Experimental Hematology and Oncology
PDF
Retrotransposon Activity in Chronic Lymphocytic Leukemia: Associations with RNA Splicing and TP53 Dysfunction
2026
·
Anastasiya Volakhava
, Sarka Pavlova
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia – consensus of expert panel from certified centres in Czechia and Slovakia for 2025
2025
·
František Folber
, Flóra Benkö
, et al.
·
Transfuze a hematologie dnes
Is long-term administration of interferons in polycythaemia vera associated with risks?
2025
·
Josef Suchopár
, Michael Doubek
·
Transfuze a hematologie dnes
Pancytopenia as the main manifestation of human immunodeficiency virus infection in the AIDS stage
2021
·
Pavel Polák
, Leoš Křen
, et al.
·
Vnitřní lékařství
PDF
Uncovering rare hematological entities: Shwachman-Diamond syndrome in a pair of siblings with neutropenia and recurrent infections.
2020
·
Jakub Trizuljak
, Zuzana Vrzalová
, et al.
Usefulness of chemokine receptor CCR4 for diagnosis of cutaneous T-cell lymphomas by flow cytometry.
2017
·
Jitka Novotná
, Petra Fialová
, et al.
Detection of CD26 expression in patients with mycosis fungoides.
2015
·
Jitka Osičková
, Jana Chovancová
, et al.
[The place of JAK2 inhibitors in the treatment of myelofibrosis. An amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph- myeloproliferative disorders (CZEMP)].
2014
·
Libor Červinek
, Michael Doubek
, et al.
·
PubMed
[Differential diagnostics of hypereosinophilia].
2014
·
Michael Doubek
, Yvona Brychtová
, et al.
·
PubMed
Do we know an ideal patient with immune thrombocytopenia forrituximab treatment
2010
·
Libor Červínek
, Jiří Mayer
, et al.
[What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
2008
·
M Penka
, J Schwarz
, et al.
·
PubMed
Prognostic markers and risk stratification
2007
·
Michael Doubek
, Cmunt
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
2006
·
M Penka
, M Doubek
, et al.
·
PubMed
Show more works
View as search
Works count:
21
Citation count:
42
H-index:
3
I10-index:
2
Year
Topic
Type